News Sentiment

AVNS sentiment intelligence

Avanos Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 70 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 24.93 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 70

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+0.0% over one week, -0.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active -0.1% over four weeks
Fair value 41.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 55
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 70
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 19
TradingView 8
AD HOC NEWS 4
PR Newswire 3
TradingKey 3
Quartr 2
Stock Titan 2
StockStory 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 25
Deals and strategy 12
Macro sensitivity 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 70
AD HOC NEWS Direct company coverage

Avanos Medical Stock - Long-term strategy in focus for medtech specialist

Avanos Medical focuses on single-use medical devices for pain management and minimally invasive care. The article highlights the company's long-term strategy, portfolio mix, and market positioning against larger medtech competitors. It also discusses Avanos's revenue drivers, cap

Tone
Positive 63/100
Event
Earnings
Published
20 Jun 2026 19:10
Source
AD HOC NEWS
TradingKey Direct company coverage

Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 172nd in its industry, with an average analyst price target of $14.00. One analyst currently rates the stock as "Hold". The company's expected revenue for the next quarter is $173.00 million, and its EPS

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 09:10
Source
TradingKey
TradingKey Direct company coverage

Avanos Medical Inc (AVNS) Financial Health: Profitability & Balance Sheet Analysis

Avanos Medical Inc (AVNS) has a strong financial health score of 7.17, ranking 104 out of 204 in its industry. The company demonstrated robust operating efficiency with a year-over-year revenue increase of 8.78% to $182.20M and a net profit increase of 22.73%. This analysis highl

Tone
Positive 72/100
Event
Earnings
Published
17 Jun 2026 22:10
Source
TradingKey